GTF3C3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.158200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.438000E-01
Normal-vs-Stage2
7.439000E-01
Normal-vs-Stage3
5.233700E-02
Normal-vs-Stage4
4.806800E-01
Stage1-vs-Stage2
8.549800E-01
Stage1-vs-Stage3
2.070300E-02
Stage1-vs-Stage4
2.778200E-01
Stage2-vs-Stage3
8.059900E-02
Stage2-vs-Stage4
8.852000E-02
Stage3-vs-Stage4
8.942400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.505200E-01
Normal-vs-AfricanAmerican
5.447200E-01
Normal-vs-Asian
3.955000E-01
Caucasian-vs-AfricanAmerican
8.078600E-01
Caucasian-vs-Asian
2.349000E-01
AfricanAmerican-vs-Asian
5.533200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.666400E-01
Normal-vs-Female
7.794000E-01
Male-vs-Female
7.399600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.139200E-01
Normal-vs-Age(41-60Yrs)
9.813400E-01
Normal-vs-Age(61-80Yrs)
5.775400E-01
Normal-vs-Age(81-100Yrs)
8.124400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.124400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.012600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.404800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.188100E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.888000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.952000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.771400E-01
Normal-vs-Daily Drinker
3.300800E-01
Normal-vs-Weekly Drinker
9.585800E-01
Normal-vs-Occasional Drinker
5.699000E-01
Normal-vs-Social Drinker
7.617200E-01
Non Drinker-vs-Daily Drinker
6.334000E-01
Non Drinker-vs-Weekly Drinker
4.891000E-01
Non Drinker-vs-Occasional Drinker
1.301730E-02
Non Drinker-vs-Social Drinker
3.821400E-01
Daily Drinker-vs-Weekly Drinker
3.554600E-01
Daily Drinker-vs-Occasional Drinker
4.062100E-03
Daily Drinker-vs-Social Drinker
1.928950E-01
Weekly Drinker-vs-Occasional Drinker
5.126600E-01
Weekly Drinker-vs-Social Drinker
8.471200E-01
Occasional Drinker-vs-Social Drinker
1.247590E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.018000E-02
Normal-vs-Grade 2
3.938500E-02
Normal-vs-Grade 3
1.522180E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.156200E-02
Grade 1-vs-Grade 3
2.039400E-03
Grade 1-vs-Grade 4
7.018000E-02
Grade 2-vs-Grade 3
5.464500E-02
Grade 2-vs-Grade 4
3.938500E-02
Grade 3-vs-Grade 4
1.522180E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.559000E-01
Normal-vs-NonDiabetic
6.660800E-01
Diabetic-vs-NonDiabetic
7.084200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.310000E-01
Normal-vs-NoPancreatitis
6.819600E-01
Pancreatitis-vs-NoPancreatitis
5.462600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.511400E-01
Normal-vs-N1
7.475800E-01
N0-vs-N1
7.192600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.388600E-01
Normal-vs-TP53-NonMutant
6.313600E-01
TP53-Mutant-vs-TP53-NonMutant
1.883800E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
